These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17608873)

  • 1. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction: a subgroup analysis of elderly subjects from the China Coronary Secondary Prevention Study.
    Ye P; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Am Geriatr Soc; 2007 Jul; 55(7):1015-22. PubMed ID: 17608873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    J Clin Pharmacol; 2009 Aug; 49(8):947-56. PubMed ID: 19602720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
    Zhao SP; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC; Liu L; Ye HJ; Wu ZH;
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):81-4. PubMed ID: 17312447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Ann Med; 2010 Apr; 42(3):231-40. PubMed ID: 20350253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [China coronary secondary prevention study (CCSPS): outcomes from analysis of coronary heart disease patients with diabetes].
    Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1067-70. PubMed ID: 16563271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [China coronary secondary prevention study (CCSPS)].
    Lu ZL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):109-15. PubMed ID: 15924803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS).
    Li JJ; Lu ZL; Kou WR; Chen Z; Wu YF; Yu XH; Zhao YC;
    Clin Exp Hypertens; 2010; 32(8):491-8. PubMed ID: 21091365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
    Lu Z; Kou W; Du B; Wu Y; Zhao S; Brusco OA; Morgan JM; Capuzzi DM; ; Li S
    Am J Cardiol; 2008 Jun; 101(12):1689-93. PubMed ID: 18549841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The beneficial effects of lipid-lowering therapy with xuezhikang on cardiac events and total mortality in coronary heart disease patients with or without hypertension: a random, double-blinded, placebo controlled clinical trial].
    DU BM; Lu ZL; Chen Z; Wu YF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):890-4. PubMed ID: 17217713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [China coronary secondary prevention study: analysis of patients with different myocardial infarction history].
    Du BM; Lu ZL; Chen Z; Wu YF; Zhao WD; Huang TG;
    Zhonghua Nei Ke Za Zhi; 2006 Jan; 45(1):21-4. PubMed ID: 16624082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention clinics for coronary heart disease: a 10-year follow-up of a randomised controlled trial in primary care.
    Delaney EK; Murchie P; Lee AJ; Ritchie LD; Campbell NC
    Heart; 2008 Nov; 94(11):1419-23. PubMed ID: 18198203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influencing factors of surviving time of patients with non-ST elevation acute coronary syndromes in China].
    Liang Y; Zhu J; Tan HQ; Li JD; Liu LS
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):873-8. PubMed ID: 16029522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
    Neil HA; DeMicco DA; Luo D; Betteridge DJ; Colhoun HM; Durrington PN; Livingstone SJ; Fuller JH; Hitman GA;
    Diabetes Care; 2006 Nov; 29(11):2378-84. PubMed ID: 17065671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
    Chen KJ; Shi DZ; Xu H; Lü SZ; Li TC; Ke YN; Zhang MZ; Lu XY; Sun RY; You SJ
    Chin Med J (Engl); 2006 Jan; 119(1):6-13. PubMed ID: 16454975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number-needed-to-treat analysis of the prevention of myocardial infarction and death by antidyslipidemic therapy.
    Rembold CM
    J Fam Pract; 1996 Jun; 42(6):577-86. PubMed ID: 8656168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender based differences in patients with acute coronary syndrome: findings from Chinese Registry of Acute Coronary Events (CRACE).
    Song XT; Chen YD; Pan WQ; Lü SZ;
    Chin Med J (Engl); 2007 Jun; 120(12):1063-7. PubMed ID: 17637223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.